Back to JACOBS LEVY EQUITY MANAGEMENT, INC JACOBS LEVY EQUITY MANAGEMENT, INC

PYXSPYXS
7 quarters

Position history for JACOBS LEVY EQUITY MANAGEMENT, INCJACOBS LEVY EQUITY MANAGEMENT, INC's holdings in PYXIS ONCOLOGY INC

Yes. Jacobs Levy Equity Management holds 428,606 shares of PYXS (Pyxis Oncology), worth $1.3M, as of its Q2 2026 13F filing. It reduced the position by 32,391 shares (-7.0%) from Q1 2026. Jacobs Levy Equity Management has held PYXS since Q1 2026, across 2 quarterly 13F filings.

Current Value

$1.3M

Current Shares

428,606

Total Value Change

-$114,919

Total Shares Change

+45,766

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
428,606
-7.0%
$1.3M0.0%$3.01
0
2026-Q1
New
460,997
-
$673,0560.0%$1.43
34
2025-Q4
Exited
0
-100.0%
$00.0%$1.09
0
2025-Q3
New
60,333
-
$133,9390.0%$2.20
31
2025-Q1
Exited
0
-100.0%
$00.0%$1.06
0
2024-Q4
Increased
601,940
+57.2%
$939,0260.0%$1.56
36
2024-Q3
New
382,840
-
$1.4M0.0%$3.62
35

Other major holders of PYXS: RA CAPITAL MANAGEMENT, L.P., RTW INVESTMENTS, LP, CITADEL ADVISORS LLC, Janus Henderson Group Ltd., BALYASNY ASSET MANAGEMENT L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used